鸿瑞泰捷

Biotech/Healthcare

Since September 2016, Hongrui Taijie has focused on the R&D, production, and commercialization of microfluidic chip-based testing technologies. Combining its core microfluidic technology with protein coating and chemiluminescence detection, the company has established a high-performance…

Latest round: Series A (2022)